Quest Diagnostics Inc (DGX) Institutional Ownership Tracker (Q2 2026)

DGX ranks #401 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

1113 institutions disclose a position in DGX, but none treat it as a major bet — even M.D. Sass, LLC, its most concentrated holder, allocates just 5.0% of its own portfolio to it.

Eastern Bank has added to its DGX position for two straight quarters, increasing it by $33.1M to reach $48.4M today.

DGX is down 1.7% today, but institutions show net buying of $6.4B this quarter — a divergence between today's price move and the underlying institutional flow.

DGX posted net income of $1.1B over the trailing twelve months.

• Profitable — net income of $1.1B over the trailing twelve months
• Revenue grew 9.9% year over year
• Net income improved year over year, from $950.0M to $1.1B
• Generated $1.9B in positive operating cash flow
• Current ratio of 1.04x — below the conventional 1.5x liquidity buffer
• Liabilities run x equity — a highly leveraged balance sheet worth noting